Highlights from articles featured in the September issue of Contemporary OB/GYN.
Let the editorial staff of Contemporary OB/GYN know what you thought of this month’s feature stories by tagging us on Facebook and Twitter (@ContempOBGYN) or send us an email at info.contemporaryobgyn.net.
The September issue of Contemporary OB/GYN discussed sensitive subjects, such as racism, implicit bias, mental health, sexism, and representation. Below is a recap of those featured on the cover:
Any professional who is exposed to high levels of stress is at risk. Physicians are especially vulnerable. e characteristics that are emphasized and rewarded during medical training are the same ones that make a physician vulnerable to burnout. Read the full article here.
The virtual well-woman visit is an ideal opportunity to promote healthy lifestyles, ensure appropriate screening for various conditions, and counsel patients on risk-reducing behavior. Successful adoption and uptake of telehealth may allow for interventions and care of patients at an unprecedented rate. Read the full article here.
The breathtaking physiology of reproduction may go astray in any facet and result in infertility. Evaluation for that aberration, followed by diagnosis-specific treatment, is perhaps the most cost-e effective way to help a couple conceive. is is an opportune time to add antenatal screening to the basic diagnostic evaluation of the infertile couple. Read the full article here.
Driven by the cost-effective introduction of next-generation sequencing, prenatal screening for fetal genetic disease has dramatically expanded. Although noninvasive prenatal testing (NIPT) for the common aneuploidies (trisomy 21, 18, and 13) has had the greatest uptake and gained the most attention, fetal Mendelian disorders actually affect more pregnancies. Read the full article here.
View the September Digital Edition for more peer-reviewed content.
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More